8/12/2019 referncias_HLA_doenas
1/2
REFERNCIAS
N. Mahdi, A. M. Al-Subaie, K. Al-Ola, A. Q. Al-Irhayim, M. E.
Ali, Z. Al-Irhayim, W. Y. Almawi;HLA DRB1*130101-DQB1*060101
haplotype is associated with acute chest syndrome insickle cell
anemia patients; Tissue Antigens; 73, 3 : 245 249, 2009.
Mahdi, Najat, Al-Ola, Khadija, Al-Subaie, Abeer M., Ali,
Muhallab E., Al-Irhayim, Zaid, Al-Irhayim, A. Qader, Almawi, Wassim
Y. HLA Class II Haplotypes Distinctly Associated withVaso-Occlusion
in Children with Sickle Cell Disease ; Clin. Vaccine Immunol. 15:
729-731,2008.
Lori A. Styles, Carolyn Hoppe, William Klitz, Elliott Vichinsky,
Bertram Lubin, ElizabethTrachtenberg; Evidence for HLA-related
susceptibility for stroke in children with sicklecell disease .
Blood 95:3562-3567, 2000.
Carolyn Hoppe, William Klitz, Janelle Noble, Lara Vigil, Elliott
Vichinsky, Lori Styles; DistinctHLA associations by stroke subtype
in children with sickle cell anemia . Bloo;
v.101:2865-2869;2003
JOUR,Al-Ola, K., Mahdi, N., Al-Subaie, A. M., Ali, M. E.,
Al-Absi, I. K., Almawi, W. Y.; Evidencefor HLA class II susceptible
and protective haplotypes for osteomyelitis in pediatricpatients
with sickle cell anemia . Tissue Antigens, v.71,5: 453
457,2008.
Tamouza R, Busson M, Fortier C, Diagne I, Diallo D, Sloma I,
Contouris H, Krishnamoorthy R, Labie D, Girot R, Charron D.
HLA-E*0101 allele in homozygous state favors severebacterial
infections in sickle cell anemia . Hum Immunol. 2007
Oct;68(10):849-53. Epub 2007Sep 19.
Tamouza R, Neonato MG, Busson M, Marzais F, Girot R, Labie D,
Elion J, Charron D. Infectious complications in sickle cell disease
are influenced by HLA class II alleles . HumImmunol. 2002
Mar;63(3):194-9.
JOANNES M.O et al. HLA polymorphism and s i c k l e c e l l d i
s e a s e . Hal-00387082, version 1 -23 May 2009. Disponvel
em:http://hal.archivesouvertes.fr/docs/00/38/70/82/PDF/MO_JOANNES_et_al_HLA_and_SCD.pdf
Acesso em: 25/05/2011 -17:00h
E. A. A. Cordero,T. D. Veit, M. A. L. Da Silva, S. M. C.
Jacques, L. M. D. R. Silla, J. A. B. Chies.
HLA-G polymorphism influences the susceptibility to HCV
infection in sickle cell diseasepatients . Tissue Antigens; Volume
74, Issue 4, p ages 308 313, October 2009
Wieland I, Wermes C, Eifrig B, Holstein K, Pollmann H, Siegmund
B, Bidlingmaier C, Kurnik K, Nimtz-Talaska A, Niekrens C, Eisert R,
Tiede A, Ebenebe C, Lakomek M, Hoy L, Welte K, Sykora KW.
Inhibitor-Immunology-Study. Different HLA-types seem to be involved
in theinhibitor development in haemophilia A. Hamostaseologie. 2008
Oct;28 Suppl 1:S26-8.
Hay CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC,
Colvin BT, Hill FG, Preston
FE, Peake IR. HLA class II profile: a weak determinant of factor
VIII inhibitor development
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tamouza%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Busson%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Fortier%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Diagne%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Diallo%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Sloma%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Contouris%20H%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Krishnamoorthy%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Labie%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Girot%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Charron%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tamouza%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Neonato%20MG%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Busson%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Marzais%20F%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Girot%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Labie%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Elion%20J%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Charron%20D%22%5BAuthor%5Dhttp://hal.archivesouvertes.fr/docs/00/38/70/82/PDF/MO_JOANNES_et_al_HLA_and_SCD.pdfhttp://hal.archivesouvertes.fr/docs/00/38/70/82/PDF/MO_JOANNES_et_al_HLA_and_SCD.pdfhttp://onlinelibrary.wiley.com/doi/10.1111/tan.2009.74.issue-4/issuetochttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wieland%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wermes%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Eifrig%20B%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Holstein%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Pollmann%20H%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Siegmund%20B%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Bidlingmaier%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Kurnik%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Nimtz-Talaska%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Niekrens%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Eisert%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tiede%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Ebenebe%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Lakomek%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hoy%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Welte%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Sykora%20KW%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hay%20CR%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Ollier%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Pepper%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Cumming%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Keeney%20S%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Goodeve%20AC%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Colvin%20BT%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hill%20FG%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Preston%20FE%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Preston%20FE%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Peake%20IR%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Peake%20IR%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Preston%20FE%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Preston%20FE%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hill%20FG%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Colvin%20BT%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Goodeve%20AC%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Keeney%20S%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Cumming%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Pepper%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Ollier%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hay%20CR%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Sykora%20KW%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Welte%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hoy%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Lakomek%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Ebenebe%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tiede%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Eisert%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Niekrens%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Nimtz-Talaska%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Kurnik%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Bidlingmaier%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Siegmund%20B%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Pollmann%20H%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Holstein%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Eifrig%20B%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wermes%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wieland%20I%22%5BAuthor%5Dhttp://onlinelibrary.wiley.com/doi/10.1111/tan.2009.74.issue-4/issuetochttp://hal.archivesouvertes.fr/docs/00/38/70/82/PDF/MO_JOANNES_et_al_HLA_and_SCD.pdfhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Charron%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Elion%20J%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Labie%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Girot%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Marzais%20F%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Busson%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Neonato%20MG%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tamouza%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Charron%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Girot%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Labie%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Krishnamoorthy%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Contouris%20H%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Sloma%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Diallo%20D%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Diagne%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Fortier%20C%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Busson%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tamouza%20R%22%5BAuthor%5D
8/12/2019 referncias_HLA_doenas
2/2
in severe haemophilia A. UKHCDO Inhibitor Working Party . Thromb
Haemost. 1997Feb;77(2):234-7.
Jeffery, K. J.M.; Usuku, K.; Nagai, M.; Osame, M; Bangham, C.
R.M. Hla-A*02 Protects
Against Ham/Tsp By Reducing Htlv-I Provirus Load. Journal of
Acquired Immune DeficiencySyndromes & Human Retrovirology.1
April 1999 - Volume 20 - Issue 4 - p A17
B. C. Catalan-Soares, Anna Brbara F. Carneiro-Proietti, F. G. Da
Fonseca, R. Correa-Oliveira, D. Peralva-Lima, R. Portela, J. G.
Ribas, D. U. Gonalves, F. A. Proietti. HLA class I alleles
inHTLV-1-associated myelopathy and asymptomatic carriers from the
Brazilian cohortGIPH. Medical Microbiology and Immunology ; Volume
198, Number 1, 1-3, 2007
Rafatpanah H, Pravica V, Faridhosseini R, Tabatabaei A, Ollier
W, Poulton K, Thomson W, Hutchinson I. Association between
HLA-DRB1*01 and HLA-Cw*08 and outcome followingHTLV-I infection.
Iran J Immunol. 2007 Jun;4(2):94-100.
http://www.springerlink.com/content/?Author=B.+C.+Catalan-Soareshttp://www.springerlink.com/content/?Author=Anna+B%c3%a1rbara+F.+Carneiro-Proiettihttp://www.springerlink.com/content/?Author=F.+G.+Da+Fonsecahttp://www.springerlink.com/content/?Author=R.+Correa-Oliveirahttp://www.springerlink.com/content/?Author=D.+Peralva-Limahttp://www.springerlink.com/content/?Author=R.+Portelahttp://www.springerlink.com/content/?Author=J.+G.+Ribashttp://www.springerlink.com/content/?Author=D.+U.+Gon%c3%a7alveshttp://www.springerlink.com/content/?Author=F.+A.+Proiettihttp://www.springerlink.com/content/0300-8584/http://www.springerlink.com/content/0300-8584/198/1/http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rafatpanah%20H%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Pravica%20V%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Faridhosseini%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tabatabaei%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Ollier%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Poulton%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Thomson%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hutchinson%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hutchinson%20I%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Thomson%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Poulton%20K%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Ollier%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Tabatabaei%20A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Faridhosseini%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Pravica%20V%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Rafatpanah%20H%22%5BAuthor%5Dhttp://www.springerlink.com/content/0300-8584/198/1/http://www.springerlink.com/content/0300-8584/http://www.springerlink.com/content/?Author=F.+A.+Proiettihttp://www.springerlink.com/content/?Author=D.+U.+Gon%c3%a7alveshttp://www.springerlink.com/content/?Author=J.+G.+Ribashttp://www.springerlink.com/content/?Author=R.+Portelahttp://www.springerlink.com/content/?Author=D.+Peralva-Limahttp://www.springerlink.com/content/?Author=R.+Correa-Oliveirahttp://www.springerlink.com/content/?Author=F.+G.+Da+Fonsecahttp://www.springerlink.com/content/?Author=Anna+B%c3%a1rbara+F.+Carneiro-Proiettihttp://www.springerlink.com/content/?Author=B.+C.+Catalan-Soares
